Axogen (AXGN) Tax Provisions (2010 - 2012)

Axogen's (AXGN) quarterly Tax Provisions came in at -$1758.0 in Q4 2012, up 99.76% quarter-over-quarter from -$736434.0 in Q2 2012.

Axogen (AXGN) Tax Provisions (2010 - 2012) Analysis & Trends

Axogen's Tax Provisions history runs 3 years deep, the most recent figure standing at -$1758.0 for Q4 2012.

  • On a quarterly basis, Tax Provisions changed N/A year-over-year to -$1758.0 in Q4 2012; TTM through Dec 2013 was -$1758.0, a 99.61% increase from a year earlier, with the FY2012 full-year figure at -$738192.0, changed N/A from the prior year.
  • Tax Provisions improved to -$1758.0 in Q4 2012 per AXGN's latest filing, from -$736434.0 in the prior quarter.
  • Across five years, Tax Provisions topped out at $286500.0 in Q2 2011 and bottomed at -$736434.0 in Q2 2012.
  • The 3-year median for Tax Provisions is -$52879.0 (2010), against an average of -$138923.0.
  • Across the five-year window, Tax Provisions jumped 375.48% in 2011 and slumped 357.05% in 2012, its largest moves.
  • Year by year, Tax Provisions stood at -$104000.0 in 2010, then soared by 375.48% to $286500.0 in 2011, then sank by 100.61% to -$1758.0 in 2012.
  • Per Business Quant, the three latest AXGN Tax Provisions figures stand at -$1758.0 (Q4 2012), -$736434.0 (Q2 2012), and $286500.0 (Q2 2011).

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Taxes (Qtr)
1 Abbott Laboratories 201.40 Bn 194.75 Bn 6.27 Bn 372.00 Mn
2 Stryker 122.29 Bn 119.41 Bn 3.81 Bn 105.00 Mn
3 Medtronic 105.01 Bn 96.40 Bn 6.41 Bn 575.00 Mn
4 Boston Scientific 64.81 Bn 63.59 Bn 3.61 Bn -176.00 Mn
5 Edwards Lifesciences 55.28 Bn 51.60 Bn 1.29 Bn 78.30 Mn
6 Dexcom 29.06 Bn 27.94 Bn 750.30 Mn 70.00 Mn
7 Koninklijke Philips 29.02 Bn 25.93 Bn 2.07 Bn -51.51 Mn
8 GE HealthCare Technologies 28.27 Bn 26.20 Bn 1.98 Bn 94.00 Mn
9 Smith & Nephew 25.80 Bn 25.22 Bn - -
10 Axogen 2.05 Bn 1.95 Bn 46.19 Mn -

Historic Data

Download Data
DateValue
Dec 31, 2012 -1,758.00
Jun 30, 2012 -736,434.00
Jun 30, 2011 286,500.00
Jun 30, 2010 -104,000.00